← Back to headlines
Piper Upgrades Regeneron to Overweight on Dupixent and Pipeline Strength
Piper Sandler has upgraded Regeneron Pharmaceuticals to an 'overweight' rating, citing strong performance from its drug Dupixent and the potential of its robust pipeline.
31 Mar, 15:23 — 31 Mar, 15:23
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Manila Water Deploys Tankers to Aid Maynilad After Pipe Break
just now
Manila Water Assists Maynilad with Tankers After Pipe Breakage in Tondo
just now
Philippine DOE Official Admits Fuel Price Adjustments Lead to Cartel-like Behavior
just now